|   | 
|    | FDA issues guidelines for bioengineered plants 
  (Thursday, Sept. 12, 2002 -- CropChoice news) --  
The FDA's Center for Biologics Evaluation and Research is seeking public
   comments within 120 days of the date of publication in the Federal
   Register, expected on September 12, on a draft document entitled "Guidance
   for Industry: Drugs, Biologics, and Medical From Bioengineered Plants for
   Use in Humans and Animals." 
   This document is intended to provide guidance to sponsors, manufacturers,
   licensees, and applicants of products derived from bioengineered plants or
   plant materials. An electronic copy of the draft, which was prepared in
   collaboration with USDA, is posted at 
    http://www.fda.gov/OHRMS/DOCKETS/98fr/02d-0324-gdl0001.pdf | |